These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 28353376)
1. Acquired Cystic Disease-Associated Renal Cell Carcinoma: Review of Pathogenesis, Morphology, Ancillary Tests, and Clinical Features. Foshat M; Eyzaguirre E Arch Pathol Lab Med; 2017 Apr; 141(4):600-606. PubMed ID: 28353376 [TBL] [Abstract][Full Text] [Related]
2. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up. Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703 [TBL] [Abstract][Full Text] [Related]
3. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Kuroda N; Shiotsu T; Kawada C; Shuin T; Hes O; Michal M; Ohe C; Mikami S; Pan CC Ann Diagn Pathol; 2011 Aug; 15(4):282-5. PubMed ID: 20952286 [TBL] [Abstract][Full Text] [Related]
4. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885 [TBL] [Abstract][Full Text] [Related]
5. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047 [TBL] [Abstract][Full Text] [Related]
6. Paneth-like cells in renal cell carcinomas and in cysts associated with acquired cystic kidney disease: Clinicopathologic analysis, comparative study and description of precursor lesions. Kojima F; Alaghehbandan R; Kuroda N; Matsuzaki I; Mikasa Y; Musangile FY; Iwamoto R; Takahashi Y; Iwahashi Y; Warigaya K; Iba A; Hara I; Murata SI; Hes O Ann Diagn Pathol; 2021 Apr; 51():151707. PubMed ID: 33516060 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions. Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189 [TBL] [Abstract][Full Text] [Related]
8. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study. Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581 [TBL] [Abstract][Full Text] [Related]
9. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Sule N; Yakupoglu U; Shen SS; Krishnan B; Yang G; Lerner S; Sheikh-Hamad D; Truong LD Am J Surg Pathol; 2005 Apr; 29(4):443-51. PubMed ID: 15767796 [TBL] [Abstract][Full Text] [Related]
10. Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Kuroda N; Ohe C; Mikami S; Hes O; Michal M; Brunelli M; Martignoni G; Sato Y; Yoshino T; Kakehi Y; Shuin T; Lee GH Histol Histopathol; 2011 Sep; 26(9):1215-8. PubMed ID: 21751153 [TBL] [Abstract][Full Text] [Related]
11. Cytologic findings of acquired cystic disease-associated renal cell carcinoma: a report of two cases. Rivera M; Tickoo SK; Saqi A; Lin O Diagn Cytopathol; 2008 May; 36(5):344-7. PubMed ID: 18418849 [TBL] [Abstract][Full Text] [Related]
12. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
13. Acquired cystic disease-associated renal cell carcinoma: A clinicopathologic study of eight tumors with clinical follow-up. ChrabaĆska M; Ryszawy J; Drozdzowska B Indian J Cancer; 2021; 58(4):608-614. PubMed ID: 34975102 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis. Enoki Y; Katoh G; Okabe H; Yanagisawa A Histopathology; 2010 Feb; 56(3):384-94. PubMed ID: 20459538 [TBL] [Abstract][Full Text] [Related]
15. Renal-cell carcinomas in end-stage kidneys: a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma. Bhatnagar R; Alexiev BA Int J Surg Pathol; 2012 Feb; 20(1):19-28. PubMed ID: 21791489 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers]. Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583 [TBL] [Abstract][Full Text] [Related]
17. Acquired Cystic Disease-Associated Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Duong NX; Le MK; Nguyen TT; Nguyen DD; Vuong HG; Kondo T; Mitsui T Clin Genitourin Cancer; 2024 Jun; 22(3):102050. PubMed ID: 38502982 [TBL] [Abstract][Full Text] [Related]
18. [Multilocular cystic renal cell carcinoma]. Lang ZQ; Yao WD; Qu GM; Jiang L Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):574-5. PubMed ID: 17134559 [No Abstract] [Full Text] [Related]
19. Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Kuroda N; Shiotsu T; Hes O; Michal M; Shuin T; Lee GH Med Mol Morphol; 2010 Dec; 43(4):231-4. PubMed ID: 21267700 [TBL] [Abstract][Full Text] [Related]
20. Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential? Brimo F; Atallah C; Li G; Srigley JR Histopathology; 2016 Apr; 68(5):666-72. PubMed ID: 26256827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]